Design and Synthesis of Benzenesulfonamide Derivatives as Potent Anti-Influenza Hemagglutinin Inhibitors
Citations Over TimeTop 20% of 2011 papers
Abstract
Structural optimization of salicylamide-based hemagglutinin (HA) inhibitor 1 resulted in the identification of cis-3-(5-hydroxy-1,3,3-trimethylcyclohexylmethylamino)benzenesulfonamide 28 and its derivatives as potent anti-influenza agents. The lead compound 28 and its 2-chloro analogue 40 can effectively prevent cytopathic effects (CPE) caused by infection of influenza A/Weiss/43 strain (H1N1) with EC50 values of 210 and 86 nM, respectively. Mechanism of action studies indicate that 40 and its analogues inhibit the virus fusion with host endosome membrane by binding to HA and stabilizing the prefusion HA structure. With significantly improved metabolic stability, the reported series represents the first generation of orally bioavailable HA inhibitors that have a good selectivity window and potential for further development as novel anti-influenza agents.
Related Papers
- → Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin(1992)56 cited
- → C1QTNF5 is a novel attachment factor that facilitates the entry of influenza A virus(2024)2 cited
- → An Hypothesis for the Mechanism by Which an Hemagglutinin Inhibitor Affects Vaccinia Virus(1970)2 cited
- [An immunological analysis of the hemagglutinin from the influenza A virus (H1N1) isolated by using various detergents].(1990)
- → The study on influenza A ( H1N1 ) virus hemagglutinin character from human and animal(2010)